Nisa Investment Advisors
RCEL icon

Nisa Investment Advisors’s Avita Medical RCEL Stock Holding History

Nisa Investment Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$344 Buy
+93
New +$390 ﹤0.01% 2911
2025
Q2 		– Sell
-1,375
Closed -$11.2K – 3082
2025
Q1 		$11.2K Buy
1,375
+1,212
+744% +$11.3K ﹤0.01% 2070
2024
Q4 		$2.09K Hold
163
– – ﹤0.01% 2477
2024
Q3 		$1.75K Buy
163
+148
+987% +$1.39K ﹤0.01% 2428
2024
Q2 		$119 Sell
15
-31
-67% -$295 ﹤0.01% 2867
2024
Q1 		$737 Buy
46
+32
+229% +$518 ﹤0.01% 2425
2023
Q4 		$192 Buy
+14
New +$160 ﹤0.01% 2564
2022
Q2 		– Sell
-1,700
Closed -$14K – 2488
2022
Q1 		$14K Buy
+1,700
New +$15.7K ﹤0.01% 2139
2021
Q4 		– Sell
-2,500
Closed -$44 – 2304
2021
Q3 		$44 Hold
2,500
– – ﹤0.01% 1963
2021
Q2 		$51 Buy
+2,500
New +$49.3K ﹤0.01% 1938

Other funds holding RCEL

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.14B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return